Correlation Between NYSE Composite and Structure Therapeutics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Structure Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Structure Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Structure Therapeutics American, you can compare the effects of market volatilities on NYSE Composite and Structure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Structure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Structure Therapeutics.
Diversification Opportunities for NYSE Composite and Structure Therapeutics
-0.29 | Correlation Coefficient |
Very good diversification
The 3 months correlation between NYSE and Structure is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Structure Therapeutics America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Structure Therapeutics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Structure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Structure Therapeutics has no effect on the direction of NYSE Composite i.e., NYSE Composite and Structure Therapeutics go up and down completely randomly.
Pair Corralation between NYSE Composite and Structure Therapeutics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 2.15 times less return on investment than Structure Therapeutics. But when comparing it to its historical volatility, NYSE Composite is 8.77 times less risky than Structure Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Structure Therapeutics American is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 3,660 in Structure Therapeutics American on August 28, 2024 and sell it today you would lose (259.00) from holding Structure Therapeutics American or give up 7.08% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Structure Therapeutics America
Performance |
| Timeline |
NYSE Composite and Structure Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Structure Therapeutics American
Pair trading matchups for Structure Therapeutics
Pair Trading with NYSE Composite and Structure Therapeutics
The main advantage of trading using opposite NYSE Composite and Structure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Structure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will offset losses from the drop in Structure Therapeutics' long position.| NYSE Composite vs. Vita Coco | NYSE Composite vs. Franklin Wireless Corp | NYSE Composite vs. Ambev SA ADR | NYSE Composite vs. Toro Co |
| Structure Therapeutics vs. Eliem Therapeutics | Structure Therapeutics vs. HCW Biologics | Structure Therapeutics vs. Scpharmaceuticals | Structure Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |